LifeBio, Inc. v. Eva Garland Consulting, LLC

CourtDistrict Court, S.D. Ohio
DecidedMay 4, 2023
Docket2:21-cv-00722
StatusUnknown

This text of LifeBio, Inc. v. Eva Garland Consulting, LLC (LifeBio, Inc. v. Eva Garland Consulting, LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
LifeBio, Inc. v. Eva Garland Consulting, LLC, (S.D. Ohio 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO EASTERN DIVISION

LIFEBIO, INC.,

Plaintiff, Civil Action 2:21-cv-722 v. Judge Edmund A. Sargus Magistrate Judge Kimberly A. Jolson EVA GARLAND CONSULTING, LLC,

Defendant.

OPINION AND ORDER This matter is before the Court regarding a discovery dispute. Plaintiff asks the Court to strike an email produced in discovery from the exhibits filed in support of Defendant’s Motion for Summary Judgment (Docs. 71, 86) and in response to Plaintiff’s Motion for Summary Judgment (Doc. 81). (Doc. 94). For the following reasons, Plaintiff’s request is DENIED. I. BACKGROUND Plaintiff filed this lawsuit in state court on January 12, 2021, alleging breach of contract and breach of good faith and fair dealing. (Doc. 1-1). Defendant removed the action to this Court on February 19, 2021, based upon its diversity jurisdiction. (See Doc. 1). At the heart of the current discovery dispute is the parties’ Stipulated Protective Order from May 4, 2021, concerning the limitations and restrictions for documents produced during the course of the litigation. (Doc. 13). Relevant here, the Stipulated Protective Order sets forth a procedure for remedying production of privileged material, known as a clawback agreement. (Id. at 7–9). Neither party disputes the clawback agreement’s contents or validity. Discovery proceeded with the Stipulated Protective Order in effect. And, on February 24, 2022, Plaintiff produced “voluminous” materials to Defendant. (Doc. 94 at 2). Shortly thereafter, on March 16, 2022, Defendant’s counsel notified Plaintiff’s counsel via email of her belief that privileged material had been produced. (Doc. 93-1 at 2). Plaintiff’s counsel did not respond, and Defendant’s counsel sent another email eight days later, on March 24, 2022, asking for Plaintiff’s input on whether the material was privileged. (Id. at 3). A paralegal working with Plaintiff’s counsel responded the next day, writing that counsel would “get back with [Defendant’s counsel] soon” regarding “the protective-order.” (Id. at 5). After three days of silence, Defendant’s counsel

again emailed Plaintiff’s counsel, asking that Plaintiff “please let [Defendant’s counsel] know [its] position with regard to [its] recent document production that appears to contain potentially privileged information.” (Id. at 8). Still, no answer. So Defendant’s counsel tried again on March 31, 2022. (Id. at 11). Once again, Plaintiff did not respond. Five days later, on April 5, 2022, Defendant’s counsel was even more direct: I have not heard back from you with regard to LifeBio’s recent document production that may contain potentially privileged information. If I do not hear back from you before the depositions of LifeBio’s representatives, I will presume these documents are not privileged. (Id. at 13). Finally, on April 8, 2022, a paralegal for Plaintiff’s counsel responded, saying that counsel was “going through the documents” and would “be in touch.” (Doc. 93-1 at 19). Then, on April 11, 2022, Plaintiff’s counsel provided Defendant’s counsel with file names that he asserted contained privileged communications. (Id. at 18). On April 13, 2022, Defendant asked that the parties confer to discuss “the potentially privileged materials that you produced, as these materials are now discoverable and privilege has been waived in light of your refusal and/or failure to timely respond to our inquiries regarding same in accordance with the [stipulated protective order].” (Id. at 17). Plaintiff’s counsel did not respond to the request for conferral. Defendant’s counsel proceeded to use the at-issue email during the deposition of Jeff Sanders on May 5, 2022—fifty days after Plaintiff first learned it had produced privileged documents. Defendant’s counsel read the email into the record at the deposition, asking Mr. Sanders if the email “speaks for itself.” (Doc. 71 at 72, 101). Plaintiff’s counsel responded, saying We’ll stipulate for the record that this is an email that was sent from Beth Sanders to Josh Borean and it speaks for itself. And everything in that email, it says what it says. We’ll stipulate to that. If you need Jeff’s confirmation on that, Susan, after we’ve stipulated to what’s on the page here -- (Id.). Defendant’s counsel followed with two more questions, at which time Plaintiff’s counsel said, “[f]or the record, I want to object to this exhibit. This appears to be attorney/client privileged information that may have been accidentally turned over.” (Id.). Defendant’s counsel informed Plaintiff’s counsel that “[f]or the record, one, the exhibit now has been stipulated to. Number two, if it has, it was – that privilege has been waived.” (Id.). And Plaintiff’s counsel subsequently responded, “Okay. All right.” (Id.). Defendant’s counsel again used the at-issue email in deposing Lisbeth Sanders on July 22, 2022—128 days after Defendant first informed Plaintiff of the privilege issue. (Doc. 71 at 2). Plaintiff’s counsel objected to the document “and any testimony associated with this document. But for purposes of moving this forward, you can ask her – I’m going to permit at this point in time some questions on this document.” (Id. at 20). Questioning about the email proceeded. Many months passed. Then Defendant used the email in its brief in support of its Motion for Summary Judgment (Doc. 64) and included the email as an exhibit to the Motion for Summary

Judgment (see Doc. 71). Both filed on January 19, 2023—309 days after Plaintiff received notice of the privilege issue. Plaintiff filed its own Motion for Summary Judgment on the same day (Doc. 67) and responded to Defendant’s Motion on February 9, 2023 (Doc. 82). But Plaintiff did not raise any objection to Defendant’s use of the at-issue email in its Motion for Summary Judgment with the Court. So, Defendant used the at-issue email in its response to Plaintiff’s Motion for Summary Judgment. (Doc. 81 at 4). And again, Plaintiff did not raise a privilege concern with the Court. Instead, it replied to Defendant’s Response in Opposition on February 23, 2023 (Doc. 87). Finally, on March 10, 2023, Plaintiff’s counsel emailed chambers, asking for a discovery conference to address production of privileged communications—despite Defendant having used

the privileged material (1) approximately ten months prior in its deposition of Jeff Sanders (see Doc. 71 at 72), (2) approximately eight months prior in its deposition of Lisbeth Sanders (see id. at 2), and (3) fifty days prior in its Motion for Summary Judgment filing (see Doc. 64). Upon notice of the instant discovery dispute, the Court held a telephonic status conference on March 14, 2023, during which it ordered the parties to file letter briefing on the issue. The parties complied (Docs. 93, 94), and the dispute is ripe for resolution. II. DISCUSSION Naturally, the Court begins with a discussion of attorney-client privilege. As a threshold matter, the Court must confirm that the email at issue is privileged. See Great-W. Life & Annuity

Ins. Co. v. Am. Econ. Ins. Co., No. 2:11-CV-02082-APG, 2013 WL 5332410, at *7 (D. Nev. Sept. 23, 2013); see also Multiquip, Inc. v. Water Mgmt. Sys. LLC, 2009 WL 4261214, at *3 (D. Idaho Nov. 23, 2009) (“[W]hen deciding whether inadvertently-produced documents waives any privilege, a two-step analysis must be done. First, it must be determined if the material in question is actually privileged[.]”). Ohio law governs the applicability of the attorney-client privilege because this case is before this Court pursuant to its diversity jurisdiction. See Inhalation Plastics, Inc. v. Medex Cardio-Pulmonary, Inc., No. 2:07-CV-116, 2012 WL 3731483, at *1 (S.D. Ohio Aug. 28, 2012) (citing Fed. R. Evid. 501).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Commodity Futures Trading Commission v. Weintraub
471 U.S. 343 (Supreme Court, 1985)
In Re Sealed Case
877 F.2d 976 (D.C. Circuit, 1989)
Thomas A.J. Fausek v. Robert E. White, Selox, Inc.
965 F.2d 126 (Sixth Circuit, 1992)
United States v. Dakota
197 F.3d 821 (Sixth Circuit, 1999)
Guy v. United Healthcare Corp.
154 F.R.D. 172 (S.D. Ohio, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
LifeBio, Inc. v. Eva Garland Consulting, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lifebio-inc-v-eva-garland-consulting-llc-ohsd-2023.